yaegashi DAIKI 八重樫大輝

… Alternative Names

Yaegashi Daiki 八重樫大輝

Less

Researcher Number	50866225
Affiliation (Current)	2026: 福島県立医科大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2024: 福島県立医科大学, 医学部, 助教 2022 – 2023: 福島県立医科大学, 医学部, 博士研究員 2020 – 2021: 福島県立医科大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Basic Section 53020:Cardiology-related
Keywords	Principal Investigator 心血管疾患 / 小児がんサバイバー / DNA損傷 / 小児がん / がん治療関連心機能障害

DNA損傷からみた小児がん治療関連心機能障害発症のメカニズム探索と予知の試みPrincipal Investigator
- Principal Investigator
  
  八重樫大輝
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Fukushima Medical University
The clinical significance of DNA damage level in childhood cancer survivorsPrincipal Investigator
- Principal Investigator
  
  Yaegashi Daiki
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Fukushima Medical University

All 2024 2023 2022 2021 2020

All Journal Article Presentation

[Journal Article] An Analysis in Patients and Operators2022
- Author(s)
  Y JIn, D Yaegashi, N Hijioka et al.
- Journal Title
  
  Int. Heart J.
  
  Volume: 63 Issue: 3 Pages: 466-475
- DOI
  10.1536/ihj.22-037
- ISSN
  1349-2365, 1349-3299
- Year and Date
  2022-05-30
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17533, KAKENHI-PROJECT-22K16109, KAKENHI-PROJECT-21H04927, KAKENHI-PROJECT-20K08494
[Journal Article] D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy2022
- Author(s)
  Oikawa Masayoshi、Yaegashi Daiki、Yokokawa Tetsuro、Misaka Tomofumi、Sato Takamasa、Kaneshiro Takashi、Kobayashi Atsushi、Yoshihisa Akiomi、Nakazato Kazuhiko、Ishida Takafumi、Takeishi Yasuchika
- Journal Title
  
  Frontiers in Cardiovascular Medicine
  
  Volume: 8 Pages: 807754-807754
- DOI
  10.3389/fcvm.2021.807754
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08493, KAKENHI-PROJECT-21K08036, KAKENHI-PROJECT-22K16109, KAKENHI-PROJECT-20K08494
[Journal Article] Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy2020
- Author(s)
  Oikawa Masayoshi、Yoshihisa Akiomi、Yokokawa Tetsuro、Misaka Tomofumi、Yaegashi Daiki、Miyata Makiko、Nakazato Kazuhiko、Ishida Takafumi、Takeishi Yasuchika
- Journal Title
  
  Oncology
  
  Volume: - Issue: 9 Pages: 1-8
- DOI
  10.1159/000507585
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K10449, KAKENHI-PROJECT-20K08493, KAKENHI-PROJECT-20K08494, KAKENHI-PROJECT-20K17123
[Journal Article] Red Blood Cell Distribution Width Is a Predictive Factor of Anthracycline-Induced Cardiotoxicity2020
- Author(s)
  Yaegashi Daiki、Oikawa Masayoshi、Yokokawa Tetsuro、Misaka Tomofumi、Kobayashi Atsushi、Kaneshiro Takashi、Yoshihisa Akiomi、Nakazato Kazuhiko、Ishida Takafumi、Takeishi Yasuchika
- Journal Title
  
  Frontiers in Cardiovascular Medicine
  
  Volume: 7 Pages: 594685-594685
- DOI
  10.3389/fcvm.2020.594685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08493, KAKENHI-PROJECT-20K08494, KAKENHI-PROJECT-20K17123
[Presentation] The sustained increase of cardiac troponin I is a relevant sign of ICI-induced myocarditis.2024
- Author(s)
  3.及川雅啓, 谷　哲矢, 八重樫大輝, 佐藤　悠, 三浦俊輔, 横川哲朗, 三阪智史, 義久精臣, 八巻尚洋, 石田隆史, 竹石恭知.
- Organizer
  第88回日本循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-22K16109
[Presentation] Subclinical cardiac dysfunction in the patients receiving anthracycline-containing chemotherapy in the chronic stage.2024
- Author(s)
  2.谷　哲矢, 及川雅啓, 大原妃美佳, 八重樫大輝, 佐藤　悠, 横川哲朗, 三浦俊輔, 三阪智史, 石田隆史, 竹石恭知.
- Organizer
  第88回日本循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-22K16109
[Presentation] Subclinical cardiac dysfunction in the patients treated with anthracycline-containing chemotherapy in the chronic phase.2023
- Author(s)
  1.Tani T, Oikawa M, Ohara H, Yaegashi D, Sato Y, Yokokawa T, Miura S, Misaka T, Ishida T, Takeishi Y
- Organizer
  American Heart Association Scientific Sessions 2023
- Data Source
  KAKENHI-PROJECT-22K16109
[Presentation] 免疫チェックポイント阻害薬使用に伴う不顕性心筋障害発症の検討.2023
- Author(s)
  5.及川雅啓, 谷　哲矢, 八重樫大輝, 大原妃美佳, 三浦俊輔, 横川哲朗, 三阪智史, 義久精臣, 八巻尚洋, 石田隆史, 竹石恭知.
- Organizer
  第6回日本腫瘍循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-22K16109
[Presentation] 小児がんサバイバーにおけるDNA損傷定量の意義2022
- Author(s)
  八重樫大輝、石田隆史、菊田敦、及川雅啓、横川哲朗、三阪智史、義久精臣、佐野秀樹、田代聡、竹石恭知
- Organizer
  第64回日本小児血液・がん学会学術集会
- Data Source
  KAKENHI-PROJECT-22K16109
[Presentation] 小児がんサバイバーにおけるDNA損傷定量の意義2021
- Author(s)
  八重樫大輝
- Organizer
  第4回日本腫瘍循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-20K17123
[Presentation] 赤血球容積粒度分布幅（RDW）によるがん治療関連心筋障害の予測2020
- Author(s)
  八重樫大輝、及川雅啓、横川哲朗、三阪智史、小林淳、義久精臣、中里和彦、石田隆史、竹石恭知
- Organizer
  第3回日本腫瘍循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-20K17123

1. ISHIDA Takafumi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 石田万里

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 及川雅啓

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

yaegashi DAIKI 八重樫 大輝

Yaegashi Daiki 八重樫 大輝

Research Projects

Research Products

Co-Researchers

DNA損傷からみた小児がん治療関連心機能障害発症のメカニズム探索と予知の試みPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The clinical significance of DNA damage level in childhood cancer survivorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] An Analysis in Patients and Operators2022

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Red Blood Cell Distribution Width Is a Predictive Factor of Anthracycline-Induced Cardiotoxicity2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] The sustained increase of cardiac troponin I is a relevant sign of ICI-induced myocarditis.2024

Author(s)

Organizer

Data Source

[Presentation] Subclinical cardiac dysfunction in the patients receiving anthracycline-containing chemotherapy in the chronic stage.2024

Author(s)

Organizer

Data Source

[Presentation] Subclinical cardiac dysfunction in the patients treated with anthracycline-containing chemotherapy in the chronic phase.2023

Author(s)

Organizer

Data Source

[Presentation] 免疫チェックポイント阻害薬使用に伴う不顕性心筋障害発症の検討.2023

Author(s)

Organizer

Data Source

[Presentation] 小児がんサバイバーにおけるDNA損傷定量の意義2022

Author(s)

Organizer

Data Source

[Presentation] 小児がんサバイバーにおけるDNA損傷定量の意義2021

Author(s)

Organizer

Data Source

[Presentation] 赤血球容積粒度分布幅（RDW）によるがん治療関連心筋障害の予測2020

Author(s)

Organizer

Data Source

yaegashi DAIKI 八重樫大輝

Yaegashi Daiki 八重樫大輝